CBD treatment reduced brain inflammation, oxidative stress, and cognitive impairment in a rat model of hepatic encephalopathy caused by liver damage.
Hepatology researchers, neuroprotection scientists, CBD therapeutic developers
CBD reduced brain inflammation and improved cognition in liver disease-induced brain damage
What the researchers found
CBD (20 mg/kg for 7 days) significantly reduced oxidative stress and inflammation in rats with liver damage-induced brain dysfunction. The treatment modulated NF-kB, ASK1, and JNK inflammatory pathways, improved NAD and serotonin levels, and enhanced cognitive performance on the Morris water maze.
Why it matters
Hepatic encephalopathy affects up to 40% of cirrhosis patients and has limited treatment options. CBD's neuroprotective effects in this model suggest a potential new therapeutic avenue.
The numbers in context
CBD at 20 mg/kg for 7 days. Reduced NF-kB, ASK1, and JNK signaling. Improved NAD and serotonin levels. Enhanced Morris water maze performance. Improved brain and liver histology.
How the study worked
Controlled rat study using thioacetamide-induced hepatic encephalopathy, with CBD and/or low-dose radiation treatment, measuring oxidative stress, inflammation, neurobehavior, and histopathology.
What this study cannot tell us
Rat model may not fully replicate human hepatic encephalopathy. Short 7-day treatment period. Combination with radiation limits ability to isolate CBD effects. Single dose tested.
How to read the evidence
Well-designed animal study with multiple molecular and behavioral outcomes, but significant translational gap to human hepatic encephalopathy.
When this study was published
2025 animal study exploring CBD neuroprotection in hepatic encephalopathy.
The bigger picture
CBD's anti-inflammatory and neuroprotective properties have been demonstrated in multiple brain injury models. Hepatic encephalopathy is a compelling clinical target because current treatments are limited to addressing the liver disease itself.
Questions still open
- Would CBD work in human hepatic encephalopathy? What is the optimal dose and duration? Could CBD complement existing treatments like lactulose and rifaximin?
Common questions
Can CBD help with brain problems caused by liver disease?
How does liver disease affect the brain?
Read the original research
Cannabidiol and low-dose γ-radiation regulate alterations consequences of hepatic-encephalopathy induced by thioacetamide: neuroprotective and anti-inflammatory role.
Immunopharmacology and immunotoxicology, 47(5), 631-644
Citation
Mostafa, Dalia M; Hassan, Asmaa A; Aboghadeer, Ahmad R; Mansour, Somaya Z; Abdel-Hamid, Gehan R. (2025). Cannabidiol and low-dose γ-radiation regulate alterations consequences of hepatic-encephalopathy induced by thioacetamide: neuroprotective and anti-inflammatory role.. Immunopharmacology and immunotoxicology, 47(5), 631-644. https://doi.org/10.1080/08923973.2025.2542131
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk